Are We Ready for the Arrival of the New COVID-19 Vaccinations? Great Promises and Unknown Challenges Still to Come
Open Access
- 18 February 2021
- Vol. 9 (2), 173
- https://doi.org/10.3390/vaccines9020173
Abstract
While the SARS-CoV-2 pandemic continues to strike and collect its death toll throughout the globe, as of 31 January 2021, the vaccine candidates worldwide were 292, of which 70 were in clinical testing. Several vaccines have been approved worldwide, and in particular, three have been so far authorized for use in the EU. Vaccination can be, in fact, an efficient way to mitigate the devastating effect of the pandemic and offer protection to some vulnerable strata of the population (i.e., the elderly) and reduce the social and economic burden of the current crisis. Regardless, a question is still open: after vaccination availability for the public, will vaccination campaigns be effective in reaching all the strata and a sufficient number of people in order to guarantee herd immunity? In other words: after we have it, will we be able to use it? Following the trends in vaccine hesitancy in recent years, there is a growing distrust of COVID-19 vaccinations. In addition, the online context and competition between pro- and anti-vaxxers show a trend in which anti-vaccination movements tend to capture the attention of those who are hesitant. Describing this context and analyzing its possible causes, what interventions or strategies could be effective to reduce COVID-19 vaccine hesitancy? Will social media trend analysis be helpful in trying to solve this complex issue? Are there perspectives for an efficient implementation of COVID-19 vaccination coverage as well as for all the other vaccinations?This publication has 22 references indexed in Scilit:
- Optimizing age-specific vaccinationScience, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine, 2021
- Vaccine Hesitancy on Social Media: Sentiment Analysis from June 2011 to April 2019Vaccines, 2021
- SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges AheadVaccines, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- COVID-19 and mRNA Vaccines—First Large Test for a New ApproachJAMA, 2020
- COVID-19 and the re-opening of schools: a policy maker’s dilemmaItalian Journal of Pediatrics, 2020
- The race for coronavirus vaccines: a graphical guideNature, 2020
- mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery, 2018
- Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sourcesBMJ, 2005